Literature DB >> 16207169

Fungal CNS infections in patients with hematologic malignancy.

Livio Pagano1, Morena Caira, Paolo Falcucci, Luana Fianchi.   

Abstract

Various fungal agents can cause CNS infections. CNS fungal infections may present as a mass (i.e., brain abscess) typically in the course of aspergillosis or zygomycosis, or may primarily involve the meninges (i.e., meningitis), as can be observed in patients with candidiasis or cryptococcosis. Most commonly, fungal brain abscesses are due to aspergillosis. CNS aspergillosis is observed particularly in acute leukemia and allogeneic hemopoietic stem cell transplantation patients. Usually, aspergillosis is localized in the lungs and secondarily spreads to the brain; only in few cases does it develop as solitary localization of CNS. In these conditions, diagnosis is very difficult because signs and symptoms can be completely aspecific. Diagnosis can often be performed only through aggressive procedures (i.e., stereotactic puncture). Zygomycetes are the second most frequent cause of brain abscesses. CNS involvement is higher than in the course of invasive aspergillosis, and this fungal complication is also characterized by a high mortality rate. In vitro and in vivo studies demonstrated that only posaconazole and lipid formulations of amphotericin B present some possibility of success in the treatment of zygomycosis, but the pharmacologic approach should always be associated with surgery. Among molds, other agents (i.e., Fusarium and Scedosporium) may also be responsible for fungal abscess. More rarely during the course of a hematologic malignancy, a meningeal candidiasis or cryptococcosis may be observed. This review mainly focuses on the epidemiology, clinical manifestations, diagnosis and management strategies of all cases of CNS fungal infections in hematologic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16207169     DOI: 10.1586/14787210.3.5.775

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

1.  Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.

Authors:  M Björkholm; M Kalin; P Grane; F Celsing
Journal:  Infection       Date:  2011-07-21       Impact factor: 3.553

Review 2.  Current concepts in antifungal pharmacology.

Authors:  Russell E Lewis
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

Review 3.  Fungal infections of the CNS: treatment strategies for the immunocompromised patient.

Authors:  Katharine E Black; Lindsey R Baden
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Role of a CUF1/CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans.

Authors:  Scott R Waterman; Moshe Hacham; Guowu Hu; Xudong Zhu; Yoon-Dong Park; Soowan Shin; John Panepinto; Tibor Valyi-Nagy; Craig Beam; Shahid Husain; Nina Singh; Peter R Williamson
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

5.  Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Sabine Mousset; Dieter Buchheidt; Werner Heinz; Markus Ruhnke; Oliver A Cornely; Gerlinde Egerer; William Krüger; Hartmut Link; Silke Neumann; Helmut Ostermann; Jens Panse; Olaf Penack; Christina Rieger; Martin Schmidt-Hieber; Gerda Silling; Thomas Südhoff; Andrew J Ullmann; Hans-Heinrich Wolf; Georg Maschmeyer; Angelika Böhme
Journal:  Ann Hematol       Date:  2013-09-12       Impact factor: 3.673

6.  Intracranial fusarium fungal abscess in an immunocompetent patient: case report and review of the literature.

Authors:  Asa Peterson; Martin H Pham; Brian Lee; Deborah Commins; Joseph Cadden; Steven L Giannotta; Gabriel Zada
Journal:  J Neurol Surg Rep       Date:  2014-11-12

Review 7.  Rare fungal infectious agents: a lurking enemy.

Authors:  Anna Skiada; Ioannis Pavleas; Maria Drogari-Apiranthitou
Journal:  F1000Res       Date:  2017-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.